TopNews

Arthritis patients who pop-in opioid pain drugs suffer with an increased risk of bone fractures and death when compared with individuals, who consume other painkillers, claims a recent study that took note of the Medicare claims records.

Researchers coming from Harvard-affiliate Brigham and Women's Hospital in Boston observed the usage rate of painkillers with regard of Medicare beneficiaries in the next seven years, and found increased levels of risks from opioids, when evaluated with other painkilling medications.

PharmaDirections appreciated Orexigen Therapeutics on receiving the FDA Advisory Board approval for their anti-obesity drug Contrave.

PharmaDirections claims it to be a proud moment with regard to Orexigen's pharmaceutical development partner and at the same time seemingly has developed and produced the first ContraveT product that completes an entire clinical development.

Orexigen achieved a major breakthrough in case of the two out of three Americans who are overweight or obese.

According to a recent US based study it has been found that kids brought up in flats have 45percent more experience to tobacco smoke than the ones who reside in detached houses.

Boffins based of Harvard and Rochester Universities, who did the experiment claimed that the exposure in flats is essentially initiated due to the smoke which sinks in side of the walls and other shared ventilation systems.

Kiran Rao, has now made her own separate identity apart from being the wife of Bollywood superstar Aamir Khan. The well acceptance of her first directorial venture Dhobi Ghat at various film festivals has inspired her to take reality dig on the `reality shows' on television.

Yash Raj Films' Mere Brother Ki Dulhan is supposed to hit the theaters in mid 2011 but the storyline is disclosed much before the release and now it is facing the wrath of this. The film starring Katrina Kaif, Imran Khan and Ali Zafar (Tere Bin Laden) deals with a story, which has very close similarity to filmmaker Onir's 2008 release Sorry Bhai.